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Abstract
Introduction: Patients with low stature normal variant growth have 
peculiar evolutionary patterns making it difficult to precisely define 
when final stature will be reached, since prediction methods are 
based on parameters of difficult quantification, such as bone age. 
Objective: To assess the agreement between two methods for 
prediction of final height based on family target range regarding 
the final height reached by adolescents with a diagnosis of normal 
variant short stature.  
Methods: Thirty-three subjects were evaluated using height 
of parents for the calculation of family target range and Bayley-
Pinneau and Tanner-Whitehouse methods for prediction of final 
height. Spearman correlation coefficient was calculated to correlate 
final height with the mean of the family target range, and the St. 
Laurent concordance coefficient was used to assess concordance 
between final stature and predictive methods. 
Results:  87.9% (29/33) subjects kept short stature at the end of 
growth and 90.9% (30/33) had a final height within family target 
range. A very strong positive correlation (Cs = 0.77; p < 0.01) was 
observed between parental mean and final height. Bayley-Pinneau 
method showed a 0.47 concordance coefficient with final height 
(95% CI: 0.34; 0.57), and Tanner-Whitehouse 3 method showed a 
concordance coefficient of 0.58 (95% CI: 0.41; 0.75). 
Conclusion: The strong positive correlation observed demonstrates 
the significant influence of parental height on final height. Neither 
method showed good concordance when used as a predictor of 
final height, with height values being overestimated.
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Short stature in children is a condition that 
causes considerable worry on the part of the parents 
and pediatricians1,2, although in most cases it represents 
normal variant situations that are only the normal extreme 
distribution of height, without the presence of diseases3. 
One of the assessments most frequently used in pediatric 
care, which can rapidly advise and reassure parents about 
child growth, is the definition of the family target range, 
which permits to determine whether a child is within 
the normal limits of expected height estimated from the 
height of the parents4. 
Various terms are used in pediatric practice to 
classify normal variants of short stature5-7 such as normal 
variant short stature, constitutional short stature, familial 
short stature, constitutional growth delay, slow familial 
maturation, and idiopathic short stature8.
The expectations of the parents, the patients and 
the professionals who monitor these children regarding 
final height have led to the necessity to formulate 
estimation methods such as calculation of family 
standard and formulas for the prediction of final height. 
Final height is influenced by genetic, endocrinologic, 
nutritional, environmental and social parameters9. The 
prediction of final height is currently considered to be 
the most important parameter for the decision of whether 
some treatment should or should not be instituted, even 
among children with no evidence of disease10.
Some factors that influence growth, especially 
the rate of maturation, show peculiar evolving patterns 
that interfere with the accuracy of the prediction of 
final height11,12. For a more accurate prediction of final 
height it is necessary to assess bone age associated with 
chronological age and with current height. One of the 
criteria used to consider that an individual has reached his 
final height is an annual increase in height of less than one 
centimeter after the pubertal spurt13. However, it is difficult 
to define exactly the final height that will be reached 
since, in general, the methods for the assessment of final 
height are faulty, are based on imprecise parameters12 and 
therefore cause this prediction to be criticized. 
The objective of the  present study was to assess 
the agreement between two methods for the prediction 
of final height and of height based on the family target 
range with the final height reached (gold standard) in 
adolescents with a diagnosis of normal variant short 
stature seen at an outpatient clinic for the evaluation of 
growth problems. 
 INTRODUCTION
A descriptive, longitudinal and retrospective 
study was conducted using selected data of medical 
records of all patients seen at the Outpatient Clinic for 
Growth and Development Problems of the University 
Hospital, Faculty of Medicine of Ribeirão Preto-USP 
(APCD-HCFMRP-USP) between 1987 and 2009. The 
inclusion criteria were: diagnosis of normal variant short 
stature, absence of associated organic disease, presented 
information that allowed the calculation of the family 
channel, radiological examination for evaluation of bone 
ageand attainment of final height, i.e., an annual increase 
in height of less than one centimeter after the pubertal 
spurt. Patients whose medical records did not provide all 
the information necessary for the study were excluded. 
Children were considered to have normal variants 
of short stature when they did not show symptoms of 
current or previous chronic diseases, with height below 
the third percentile (P3) of the growth curve for age and 
with a normal growth rate3. The subjects were divided 
into three groups according to the genetic factors that 
determine short stature: 1) familial short stature when 
the stature is appropriate for the family target range or 
genetic potential and there is no delayed bone age, and 
when the child is short because his/her parents are short; 
2) constitutional short stature when bone age is delayed - 
< 2 mean standard deviations (SD) - and height is below 
the family target range, the onset of puberty is delayed, 
the growth spurt is delayed and consequently the children 
continue to grow when their peers are no longer growing; 
3) constitutional short stature with a familial component, 
with height following the family target range, with bone 
age being delayed at least during the prepubertal period, 
 METHODS
with pubertal delay being present or not, and with final 
height ending within the family range3,6,13.
Anthropometric assessment was performed 
by trained personnel using a 200-cm long vertical 
anthropometer with 0.5 cm approximation. The parental 
mean and the family target range according to the child’s 
sex were calculated based on the height of the parents6. 
Pubertal stage was assessed according to the criteria of 
Marshall & Tanner14. Bone age was assessed before the 
onset of puberty by the methods of Greulich Pyle (GP) and 
Tanner Withehouse (TW)3, which consider the standard 
deviation (SD) and sex to define it as delayed (< 2 SD), 
accelerated (> 2SD) or compatible with chronological age. 
Two methods for the prediction of final height were 
used: 1) the Bayley-Pinneau method, which calculates 
height based on patient stature (at the time when left 
hand and wrist radiography was obtained) divided by 
the growth fraction determined according to bone age 
obtained by the GP method15; 2) the TW-3 method which 
uses chronological age, height and bone age RUS-score. 
The calculation was performed using specific software 
(RUS Child Height Prediction Utility) with application 
of the following formula: final height = current height 
+ a x RUS-score + b (where a and b are constants that 
vary according to the chronological age of the patient)16. 
The predictions were carried out before puberty due to 
the fact that bone age acceleration is greater than that of 
chronological age during puberty, reaching a peak of up 
to 1.5 year/year at an age close to the spurt17. 
The Spearman correlation coefficient (Cs) was 
used to correlate final height reached with the parental 
mean value of the family target range, and the St. Laurent 
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concordance coefficient (CCSL) was used to determine the 
concordance of final height reached (considered to be the 
gold standard) and the height values obtained by methods 
for the prediction of final height. The coefficients and 
their 95% confidence intervals were calculated by the 
bootstrap method with the aid of the SAS 9.1 software. The 
study was approved by the Research Ethics Committee of 
HCFMRP-USP, nº 6827/2009.
The Spearman correlation coefficient (Cs) between 
final height and mean parental height was calculated 
separately for the groups with normal variant short 
stature among the 33 patient. The result for the group 
as a whole was 0.77 (p-value < 0.01), demonstrating a 
very strong positive correlation between variables. The 
correlation between the groups with short stature was 
also calculated, with the following results: in the group 
with constitutional/familial short stature there was a very 
strong positive correlation between the parental mean and 
the final height, with Cs 0.82 (p < 0.01); in the group with 
constitutional short stature the correlation was moderate, 
with Cs 0.45 (p = 0.31); in the group with familial short 
stature (FSS) the correlation was strong (Cs = 0.89; p 
= 0.03) despite the small number of subjects with this 
diagnosis.
The Bayley-Pinneau method showed CCSL of 
0.47 (95% CI: 0.34 – 0.57) with final height reached, 
while the TW3 method showed CCSL of 0.58 (95% CI: 
0.41 - 0.75). With both methods, the predicted final height 
was higher than the true final height for the patients 
under study (Figure 1). The predicted height measures 
were found to have been overestimated when the height 
reached after somatic growth was assessed, a fact 
particularly observed with the Bayley-Pinneau method 
(Figures 2 and 3). The mean difference between height 
reached and predicted height for the three types of short 
stature was 8.02 cm (range: - 5 to + 19.6 cm) with the use 
of the Bayley-Pinneau method and 1.95 cm (range: – 8.8 
to + 8.9 cm) with the use of the TW3 method. It should be 
pointed out that the difference between predicted height 
and final height was calculated for each subject
Table 1: Distribution of Normal Variant Short Stature according 
to sex.
Type of SS Male Female Total
n % n % n %
CSS 5 71.4 2 28.6 7 21.2
CFSS 14 70.0 6 30.0 20 60.6
FSS 2 33.3 4 66.6 6 18.2
Total 21 63.6 12 36.4 33 100
SS: short stature CSS: constitutional short stature; C/FSS: 
constitutional/familial short stature; FSS: familial short stature.
Thirty-three patients out of 351 patients with short 
stature followed in our Outpatient Clinic were selected for 
the study since they presented an annual increase of stature 
inferior to a one centimeter after the puberal spurt registered 
in the medical record and with enough information for the 
calculation of the familiar channel. Table 1 presents the 
distribution of these patients according to the diagnosis of 
Normal Variant Short Stature, age and sex.
When they reached their final height, 30 patients 
(90.9%) had a final height within the family target range 
and 29 (87.9%) continued to have a diagnosis of short 
stature.  Table 2 shows the mean final height reached by the 
patients according to type of short stature and sex.
  Type of SS Final Parental 
mean
Male 
height(cm)
Female 
height(cm)
n mean n mean cm
CSS 5 162,2 2 149,2 166,5
CSSF 14 158,9 6 148,5 160,3
FSS 2 162,7 4 149,1 158,3
SS: short stature; CSS: constitutional short stature; CSSF: 
constitutional/familial short stature;    FSS: familial short stature.
Table 2: Distribution of mean final height according to type of 
Normal Variant Short Stature and sex
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Figure 1: Spearman correlation 
between measures of final height and 
parental mean value     [Cs: 0,77; 
p<0,01]
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Figure 2: Agreement between 
measures estimated by the Bayley-
Pineau method and final height  [CCSL 
= 0,47 (0,43;0,57)]
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Figure 3: Agreement between measures 
estimated by the TW3 method and final 
height  [CCSL = 0,58 (0,41;0,75)]
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The present study showed that most of the patients 
ended their growth with short stature and within the family 
target range. The correlation between final height reached and 
mean parental height was high for all three types of normal 
variant short stature, mainly for the variants with a familial 
component of short stature. In contrast, the correlation 
between final height reached and final height estimated by the 
methods for evaluation was moderate, with estimated final 
height being higher than the final height actually reached.
Considering that 81.5% of the patients seen at APCD-
HCFMRPUSP had a diagnosis of short stature and that 
53% of them were normal variants, it is clear that a child 
with short stature should be fully evaluated by means of 
careful anamnesis, accurate physical examination with the 
measurement of growth rate and with appropriate diagnostic 
investigation so that therapeutic proposals can be defined or 
an expectant attitude may be established when an underlying 
disease is excluded.
The higher frequency of constitutional/familial short 
stature (54.4%), followed by familial short stature (25.3%) 
reflects the importance of family inheritance regarding short 
stature18,19. Males corresponded to almost two thirds of the 
cases, a fact explained by the greater concern about growth 
among men, in addition to the psychological impact of growth 
pattern possibly affecting boys when compared to their 
peers19,20.
Among the 351 patients with short stature diagnosed, 
we only studied a sample of 33 subjects (9.4%) because some 
patients had no indication for treatment since they had a 
normal variant and, after starting pubertal growth and reaching 
a satisfactory height, they preferred to stop follow-up.
It can be seen that the groups with a familial component, 
constitutional/familial short stature and familial short stature, 
showed a very strong positive correlation between final height 
reached and the mean value for the family target range. The 
diagnosis of short stature at the end of growth demonstrates 
that parental height has a significant effect on this outcome, 
confirming the similarity of these groups regarding familial 
inheritance of growth8,19,21-23.
The two methods of assessment of final height, Bayley-
Pinneau and TW3, did not show good agreement when used 
to predict final height. In addition, they yielded final height 
estimates higher than real height. Other studies which assessed 
methods for the prediction of final height also yielded greater 
than real measures of final height used, especially considering 
the Bayley-Pinneau method23,24. Among thalassemic patients, 
the comparison of GP and TW3 for the determination of 
skeletal maturity and the prediction of final height showed 
that both methods tended to overestimate final height. The 
cited study also showed that the same method should be used 
in serial patient assessments since the two methods have 
similar reliability but their results are not equivalent25. Crowne 
et al.20 assessed final height in boys with constitutional growth 
delay and observed that there was no significant difference 
between final height and predicted adult height using the 
TW2, although they detected a significant difference between 
final height and the parental mean20. In Europe, Milner et al. 
in a study of 100 English children comparing the GP and 
TW2 methods, concluded that the methods showed a linear 
correlation among boys, but not among girls26. Bueno et al 
observed that the Bayley-Pinneau, TW2 and Roche-Wainer-
Thissen methods overestimated final height among Spanish 
children with constitutional short stature, with the Bayley-
Pinneau method being the most reliable for girls24. On the 
other hand, Ostojic reported considerable concordance 
between height estimated by the TW method and final height 
in young male Caucasian athletes; this strong correlation was 
attributed in part to the similarity of the study sample to the 
reference population for bone age27. 
If, on the one hand, the small sample of the present 
study can be considered a weak point, on the other hand, the 
study supports the need for a complete evaluation and follow-
up of children with short stature, especially regarding the 
prediction of adult height since the diagnostic and therapeutic 
management of patients with short stature and delayed 
puberty is controversial. Based on the present results and on 
literature evidence, we should emphasize the fundamental 
role of health professionals when monitoring normal variant 
short stature children considering that parental expectations 
regarding the potential height of their children and the anxiety 
of the patients themselves when facing the discrepancy in 
height compared to their peers are part of the growth problems 
seen in puericulture and general pediatric outpatient clinics. 
Thus, the management of these patients should be considered 
with caution since there are no studies with reliable methods 
for the prediction of final height to be used as the basis of 
the prescription of drugs that might raise false expectations of 
improved final height. As can be demonstrated in this study 
the BP and TW2 methods, when applied to children with a 
short stature diagnosis, were not adequate for final height 
prediction and should therefore be adopted with caution in 
situations whose diagnostic definition may imply clinical 
interventions.
Brämswig et al.28 alerted to the importance of observing 
the tendency of each method to over- or underestimate final 
height and to the wide individual variations of the estimates, 
especially considering if the patients receive or not treatment 
for the promotion of growth28. 
The main limitation of this study concerns the small 
number of subjects evaluated because as the conduct in 
these cases does not require treatment, some patients end up 
abandoning the follow up after beginning pubertal growth and 
reaching a satisfactory height.
 DISCUSSION
In view of the questions raised and of the findings 
obtained in the present study, it can be seen that the methods 
for the prediction of final height are limited for children with 
normal variant short stature. This leads to a reevaluation 
and reconsideration of the methods used for this purpose 
and of the real indication of intervention (like drugs and 
hormones) in these children in order to improve their final 
height since most of these children remains within their 
family target range.
 CONCLUSION
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Resumo
Introdução: Pacientes com baixa estatura variante normal do crescimento têm padrões evolutivos 
peculiares dificultando definir com precisão quando a estatura final será atingida, visto que os métodos 
de previsão baseiam-se em parâmetros de difícil quantificação, como a idade óssea.
Objetivo: Avaliar a concordância entre dois métodos de previsão da estatura final e do canal familiar 
com a altura final atingida (padrão ouro) por adolescentes com diagnóstico de variantes normais da 
baixa estatura atendidos em ambulatório de avaliação de problemas de crescimento. 
Método: Foram avaliados 33 sujeitos utilizando-se as estaturas dos pais para o cálculo do canal familiar 
e da média parental e os métodos Bayley-Pinneau e Tanner- Whitehouse 3 para as previsões de 
estatura final. Também foram calculados o coeficiente de correlação de Spearman para correlacionar a 
estatura final com a média do canal familiar, e o coeficiente de concordância de St. Laurent para avaliar 
a concordância entre a estatura final e os métodos de previsão. 
Resultados: 87,9% (29/33) permaneceram com Baixa Estatura ao término do crescimento e 90,9% 
(30/33) apresentaram estatura final dentro do canal familiar. Observou-se correlação positiva muito forte 
(Cs = 0,77; p < 0,01) entre a média parental e a altura final. O método de Bayley-Pinneau apresentou 
coeficiente de concordância com a altura final de 0,47 (IC 95%: 0,34; 0,57), o de TW3, 0,58 (IC 95%: 
0,41; 0,75). 
Conclusão: A correlação positiva forte demonstra a influência significativa da altura dos pais na estatura 
final. Nenhum dos dois métodos apresentou boa concordância ao serem utilizados como preditores de 
estatura final, pois os valores das alturas foram superestimados principalmente pelo método de Bayley-
Pinneau.
Palavras-chave: baixa estatura, estatura final, idade óssea.
